Summary
This 8-K filing from IDEXX LABORATORIES INC /DE (IDXX) reports the company's financial results for the fourth quarter and full year ended December 31, 2004. The key information disclosed is through a press release, which is furnished as an exhibit to this report. Investors should note that this information is being furnished under Item 2.02 and is not considered 'filed' for certain regulatory purposes, meaning it doesn't automatically trigger liability under Section 18 of the Exchange Act, nor is it automatically incorporated into other filings unless specifically referenced. While the full details of the financial results are within the furnished press release (Exhibit 99.1), the 8-K itself serves as the official notification of the release of this information. Investors seeking the specifics of IDEXX's performance for the period should refer directly to the press release for data on revenue, earnings, and any forward-looking statements or management commentary regarding their financial condition and operational results.
Key Highlights
- 1IDEXX Laboratories announced its financial results for the fourth quarter and full year ended December 31, 2004.
- 2The financial results were communicated via a press release issued on January 28, 2005.
- 3The press release is furnished as Exhibit 99.1 to this Form 8-K.
- 4The filing is made under Item 2.02 (Results of Operations and Financial Condition) of Form 8-K.
- 5Information furnished under Item 2.02 is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to its liabilities.
- 6The company's principal financial officer, Merilee Raines (VP, CFO, and Treasurer), signed the report.
- 7The 8-K primarily serves as notification that the company has released its earnings for the specified periods.